Status:
RECRUITING
Effect of 12-week Milk Fat Globule Membrane Supplementation on the Human Muscle Function of Healthy, Recreationally Active Adults
Lead Sponsor:
Loughborough University
Collaborating Sponsors:
Volac International Limited
Conditions:
Ageing Well
Neuromuscular Function
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The main aim of this study is to understand if chronic supplementation (12 weeks) of a milk fat globule membrane containing supplement, called bioactive whey protein concentrate, improves human muscle...
Detailed Description
Nutritional strategies, including supplementation, are widely sought after to improve the function of the neuromuscular system (muscle strength and power). Milk fat globule membrane (MFGM, composed of...
Eligibility Criteria
Inclusion
- 18-30 or 60-75 years old
- Male or female
- Healthy with no contraindications to exercise
- Classified as recreationally active (meet the government's guidelines for weekly physical activity - 150 minutes of moderate physical activity or 75 minutes of vigorous physical activity)
Exclusion
- Any injury, medical condition or symptom precluding the ability to complete strenuous exercise as identified by the health screen questionnaire and physical activity readiness questionnaire
- Uncontrolled hypertension (blood pressure of 140/90 mmHg or higher) as identified by recording resting blood pressure
- Neuromuscular or musculoskeletal disease
- Occurrence of a severe injury to the lower limbs or back within the previous 6 months (time loss of \> 21 days of normal activity)
- Occurrence of a minor injury to the lower limbs or back within the previous month (time loss of \>1 day of normal activity)
- Do not meet the government guidelines of minimum weekly physical activity as revealed by the IPAQ-SF
- Allergic to dairy or pea, or lactose intolerant
- Complete greater than 6 hours structured exercise per week as revealed by the exercise and physical activity form
- Consumption of supplements that may confound the results of the present study within the previous 3 months (includes any form of protein supplement, creatine, pre-workout supplements, any form of testosterone supplement, amino acids, beta-alanine, beta- hydroxy-beta-methylbutyrate (HMB), fish or krill oil, collagen supplements, any choline- containing supplement, or any phospholipid-containing supplement) as highlighted by the health screen questionnaire
- Taking anticoagulants or antiplatelet drugs
- Use of antidepressant/anti-anxiety medication
- Having a blood borne virus, or a partner who has a blood-borne virus
- Extreme diet classified as identified by the food-frequency questionnaire
Key Trial Info
Start Date :
March 28 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT06573749
Start Date
March 28 2025
End Date
January 1 2026
Last Update
April 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loughborough University
Loughborough, Leicestershire, United Kingdom, LE11 3TU